The “Drug Addiction Treatment Act of 2000” created the opportunity to expand treatment for opioid use disorder into the mainstream of medical practice, increase the number of persons treated, and have an important positive public health impact. The legislation specifies several ways in which prescribers can be considered qualified to prescribe and dispense buprenorphine in their offices for the treatment of opioid use disorder. The completion of this training fulfills the requirement prior to notifying the U.S. Department of Health and Human Services (DHHS) of their intention to begin prescribing buprenorphine for the treatment of opioid use disorder.
ABOUT THE “HALF AND HALF” COURSE
The “Half and Half” course includes both face-to-face and online components. The first half of the course consists of 4.25 hours of live face-to-face training which takes place on January 5, 2018, at York Hospital. The second half of the course consists of 3.75 hours of self-guided online training, including five modules and a required examination. After attending the first half of the course, you must complete the second half and successfully pass the examination.
The presentation and online course are designed to train qualified physicians, physician assistants and nurse practitioners in dispensing or prescribing specifically approved Schedule III, IV, and V narcotic medications for the treatment of opioid addiction in an office-based setting. The goal of this training is to acquire the knowledge and skills needed to provide optimal care to opioid use disorder patients.
Designated by the DHHS, this training meets the eight-hour requirement and is designed for prescribers to dispense buprenorphine in office practice for treatment of opioid use disorder. Participation in this training will provide participants with a comprehensive overview of buprenorphine prescribing and its safe and effective use in an office-based setting. This training is designed for physicians, physician assistants and nurse practitioners and other primary care providers who are likely to treat opioid dependent persons in their practice, such as those in family practice, general internal medicine, psychiatry, pediatrics, adolescent medicine specialists, and Opioid Treatment Programs.
Prescribers other than physicians need an additional sixteen (16) hours of training. The additional 16 hours of training is available on www.pcssmat.org at no cost. Residents can take the waiver training, however they will not be able to apply until they have a personal DEA number and an unrestricted medical license.
QUICK REGISTRATION LINK – See below
ABOUT THE PRESENTER
Leah K.Bauer, MD, is a psychiatrist and Medical Director of the Addiction Resource Center at Mid Coast Hospital in Brunswick. She graduated from the University of Cincinnati College of Medicine and went on to residency at the Massachusetts General Hospital and McLean Hospital adult psychiatry program, graduating in 2013. She has a strong interest in medication assisted treatment of substance use disorders and has led several buprenorphine x-waiver trainings as well as spoken at national meetings on these issues. She is also interested in addiction as it relates to trauma and women’s specific issues. She enjoys the outdoors and life in Maine with her husband and daughter.
Up to 4.25 CME Credits for Physicians and Physician Assistants.
This activity has been planned and implemented in accordance with the Essentials and Standards of the Maine Medical Association Committee on Continuing Medical Education and Accreditation through the partnership of Maine Medical Education Trust and CCSME. The Maine Medical Education Trust is accredited by the Maine Medical Association to provide CME activities for physicians.
Check-in will begin at 7:45 a.m. Program begins at 8:00 am.